As part of your cancer care plan, your physician has ordered molecular testing from Caris Life Sciences to better understand the biomarkers in your sample and help identify changes that control cell growth. Results from this test may help guide your personal care plan.
In order to begin testing, patient consent for molecular profiling is required. Choose the appropriate consent form below and return to Caris. Email completed form to PatientNavigator@CarisLS.com, or fax to 866-479-4925.